시장조사 보고서 : 세계의 유전성 혈관부종 시장예측 2021년-2026년

■ 영문 제목 : Global Hereditary Angioedema Market Growth 2021-2026
	■ 상품코드 : LPI-2201K00039 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 98 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료, 제약

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦5,124,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,686,000	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦10,248,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 유전성 혈관부종의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (C1 에스테라제 억제제, 칼리크레인 억제제, 선택적 브래디키닌 B2 수용체 길항제)와 용도별 시장규모 (소매 약국, 병원 약국, 온라인 약국) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 유전성 혈관부종 시장 점유율
- 지역별 유전성 혈관부종 시장규모
- 주요지역의 종류별 시장규모 (C1 에스테라제 억제제, 칼리크레인 억제제, 선택적 브래디키닌 B2 수용체 길항제)
- 주요지역의 용도별 시장규모 (소매 약국, 병원 약국, 온라인 약국)
- 미주의 유전성 혈관부종 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 유전성 혈관부종 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 유전성 혈관부종 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 유전성 혈관부종 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 유전성 혈관부종 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Pharming Group NV, Takeda, CSL Limited, iBio Inc., BioCryst Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc.
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Hereditary Angioedema will have significant change from previous year. By the most conservative estimates of global Hereditary Angioedema market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 1620.7 million in 2020. Over the next five years the Hereditary Angioedema market will register a 7.6% CAGR in terms of revenue, the global market size will reach US$ 2168.5 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Hereditary Angioedema market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Pharming Group NV
Takeda
CSL Limited
iBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hereditary Angioedema Consumption 2016-2026
2.1.2 Hereditary Angioedema Consumption CAGR by Region
2.2 Hereditary Angioedema Segment by Type
2.2.1 C1 Esterase Inhibitor
2.2.2 Kallikrein Inhibitor
2.2.3 Selective Bradykinin B2 Receptor Antagonist
2.3 Hereditary Angioedema Sales by Type
2.3.1 Global Hereditary Angioedema Sales Market Share by Type (2016-2021)
2.3.2 Global Hereditary Angioedema Revenue and Market Share by Type (2016-2021)
2.3.3 Global Hereditary Angioedema Sale Price by Type (2016-2021)
2.4 Hereditary Angioedema Segment by Distribution Channel
2.4.1 Retail Pharmacies
2.4.2 Hospital Pharmacies
2.4.3 Online Pharmacies
2.5 Hereditary Angioedema Sales by Distribution Channel
2.5.1 Global Hereditary Angioedema Sale Market Share by Distribution Channel (2016-2021)
2.5.2 Global Hereditary Angioedema Revenue and Market Share by Distribution Channel (2016-2021)
2.5.3 Global Hereditary Angioedema Sale Price by Distribution Channel (2016-2021)

3 Global Hereditary Angioedema by Company
3.1 Global Hereditary Angioedema Sales Market Share by Company
3.1.1 Global Hereditary Angioedema Sales by Company (2019-2021)
3.1.2 Global Hereditary Angioedema Sales Market Share by Company (2019-2021)
3.2 Global Hereditary Angioedema Revenue Market Share by Company
3.2.1 Global Hereditary Angioedema Revenue by Company (2019-2021)
3.2.2 Global Hereditary Angioedema Revenue Market Share by Company (2019-2021)
3.3 Global Hereditary Angioedema Sale Price by Company
3.4 Global Manufacturers Hereditary Angioedema Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hereditary Angioedema Product Location Distribution
3.4.2 Players Hereditary Angioedema Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Hereditary Angioedema by Region
4.1 Global Hereditary Angioedema by Region
4.1.1 Global Hereditary Angioedema Sales by Region
4.1.2 Global Hereditary Angioedema Revenue by Region
4.2 Americas Hereditary Angioedema Sales Growth
4.3 APAC Hereditary Angioedema Sales Growth
4.4 Europe Hereditary Angioedema Sales Growth
4.5 Middle East & Africa Hereditary Angioedema Sales Growth

5 Americas
5.1 Americas Hereditary Angioedema Sales by Country
5.1.1 Americas Hereditary Angioedema Sales by Country (2016-2021)
5.1.2 Americas Hereditary Angioedema Revenue by Country (2016-2021)
5.2 Americas Hereditary Angioedema Sales by Type
5.3 Americas Hereditary Angioedema Sales by Distribution Channel
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Hereditary Angioedema Sales by Region
6.1.1 APAC Hereditary Angioedema Sales by Region (2016-2021)
6.1.2 APAC Hereditary Angioedema Revenue by Region (2016-2021)
6.2 APAC Hereditary Angioedema Sales by Type
6.3 APAC Hereditary Angioedema Sales by Distribution Channel
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Hereditary Angioedema by Country
7.1.1 Europe Hereditary Angioedema Sales by Country (2016-2021)
7.1.2 Europe Hereditary Angioedema Revenue by Country (2016-2021)
7.2 Europe Hereditary Angioedema Sales by Type
7.3 Europe Hereditary Angioedema Sales by Distribution Channel
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Hereditary Angioedema by Country
8.1.1 Middle East & Africa Hereditary Angioedema Sales by Country (2016-2021)
8.1.2 Middle East & Africa Hereditary Angioedema Revenue by Country (2016-2021)
8.2 Middle East & Africa Hereditary Angioedema Sales by Type
8.3 Middle East & Africa Hereditary Angioedema Sales by Distribution Channel
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Hereditary Angioedema Distributors
10.3 Hereditary Angioedema Customer

11 Global Hereditary Angioedema Market Forecast
11.1 Global Hereditary Angioedema Forecast by Region
11.1.1 Global Hereditary Angioedema Forecast by Regions (2021-2026)
11.2.2 Global Hereditary Angioedema Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Hereditary Angioedema Forecast by Type
11.7 Global Hereditary Angioedema Forecast by Distribution Channel

12 Key Players Analysis
12.1 Pharming Group NV
12.1.1 Pharming Group NV Company Information
12.1.2 Pharming Group NV Hereditary Angioedema Product Offered
12.1.3 Pharming Group NV Hereditary Angioedema Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Pharming Group NV Main Business Overview
12.1.5 Pharming Group NV Latest Developments
12.2 Takeda
12.2.1 Takeda Company Information
12.2.2 Takeda Hereditary Angioedema Product Offered
12.2.3 Takeda Hereditary Angioedema Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Takeda Main Business Overview
12.2.5 Takeda Latest Developments
12.3 CSL Limited
12.3.1 CSL Limited Company Information
12.3.2 CSL Limited Hereditary Angioedema Product Offered
12.3.3 CSL Limited Hereditary Angioedema Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 CSL Limited Main Business Overview
12.3.5 CSL Limited Latest Developments
12.4 iBio Inc.
12.4.1 iBio Inc. Company Information
12.4.2 iBio Inc. Hereditary Angioedema Product Offered
12.4.3 iBio Inc. Hereditary Angioedema Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 iBio Inc. Main Business Overview
12.4.5 iBio Inc. Latest Developments
12.5 BioCryst Pharmaceuticals, Inc.
12.5.1 BioCryst Pharmaceuticals, Inc. Company Information
12.5.2 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Product Offered
12.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 BioCryst Pharmaceuticals, Inc. Main Business Overview
12.5.5 BioCryst Pharmaceuticals, Inc. Latest Developments
12.6 Ionis Pharmaceuticals, Inc.
12.6.1 Ionis Pharmaceuticals, Inc. Company Information
12.6.2 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Product Offered
12.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Ionis Pharmaceuticals, Inc. Main Business Overview
12.6.5 Ionis Pharmaceuticals, Inc. Latest Developments
…

13 Research Findings and Conclusion

List of Tables
Table 1. Hereditary Angioedema Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of C1 Esterase Inhibitor
Table 3. Major Players of Kallikrein Inhibitor
Table 4. Major Players of Selective Bradykinin B2 Receptor Antagonist
Table 5. Global Hereditary Angioedema Sales by Type (2016-2021) & (MT)
Table 6. Global Hereditary Angioedema Sales Market Share by Type (2016-2021)
Table 7. Global Hereditary Angioedema Revenue by Type (2016-2021) & ($ million)
Table 8. Global Hereditary Angioedema Revenue Market Share by Type (2016-2021)
Table 9. Global Hereditary Angioedema Sale Price by Type (2016-2021)
Table 10. Global Hereditary Angioedema Sales by Distribution Channel (2016-2021) & (MT)
Table 11. Global Hereditary Angioedema Sales Market Share by Distribution Channel (2016-2021)
Table 12. Global Hereditary Angioedema Value by Distribution Channel (2016-2021)
Table 13. Global Hereditary Angioedema Revenue Market Share by Distribution Channel (2016-2021)
Table 14. Global Hereditary Angioedema Sale Price by Distribution Channel (2016-2021)
Table 15. Global Hereditary Angioedema Sales by Company (2019-2021) & (MT)
Table 16. Global Hereditary Angioedema Sales Market Share by Company (2019-2021)
Table 17. Global Hereditary Angioedema Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Hereditary Angioedema Revenue Market Share by Company (2019-2021)
Table 19. Global Hereditary Angioedema Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Hereditary Angioedema Producing Area Distribution and Sales Area
Table 21. Players Hereditary Angioedema Products Offered
Table 22. Hereditary Angioedema Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Hereditary Angioedema Sales by Region (2016-2021) (MT)
Table 26. Global Hereditary Angioedema Sales Market Share by Region (2016-2021)
Table 27. Global Hereditary Angioedema Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Hereditary Angioedema Revenue Market Share by Region (2016-2021)
Table 29. Americas Hereditary Angioedema Sales by Country (2016-2021) & (MT)
Table 30. Americas Hereditary Angioedema Sales Market Share by Country (2016-2021)
Table 31. Americas Hereditary Angioedema Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Hereditary Angioedema Revenue Market Share by Country (2016-2021)
Table 33. Americas Hereditary Angioedema Sales by Type (2016-2021) & (MT)
Table 34. Americas Hereditary Angioedema Sales Market Share by Type (2016-2021)
Table 35. Americas Hereditary Angioedema Sales by Distribution Channel (2016-2021) & (MT)
Table 36. Americas Hereditary Angioedema Sales Market Share by Distribution Channel (2016-2021)
Table 37. APAC Hereditary Angioedema Sales by Region (2016-2021) & (MT)
Table 38. APAC Hereditary Angioedema Sales Market Share by Region (2016-2021)
Table 39. APAC Hereditary Angioedema Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Hereditary Angioedema Revenue Market Share by Region (2016-2021)
Table 41. APAC Hereditary Angioedema Sales by Type (2016-2021) & (MT)
Table 42. APAC Hereditary Angioedema Sales Market Share by Type (2016-2021)
Table 43. APAC Hereditary Angioedema Sales by Distribution Channel (2016-2021) & (MT)
Table 44. APAC Hereditary Angioedema Sales Market Share by Distribution Channel (2016-2021)
Table 45. Europe Hereditary Angioedema Sales by Country (2016-2021) & (MT)
Table 46. Europe Hereditary Angioedema Sales Market Share by Country (2016-2021)
Table 47. Europe Hereditary Angioedema Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Hereditary Angioedema Revenue Market Share by Country (2016-2021)
Table 49. Europe Hereditary Angioedema Sales by Type (2016-2021) & (MT)
Table 50. Europe Hereditary Angioedema Sales Market Share by Type (2016-2021)
Table 51. Europe Hereditary Angioedema Sales by Distribution Channel (2016-2021) & (MT)
Table 52. Europe Hereditary Angioedema Sales Market Share by Distribution Channel (2016-2021)
Table 53. Middle East & Africa Hereditary Angioedema Sales by Country (2016-2021) & (MT)
Table 54. Middle East & Africa Hereditary Angioedema Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Hereditary Angioedema Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Hereditary Angioedema Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Hereditary Angioedema Sales by Type (2016-2021) & (MT)
Table 58. Middle East & Africa Hereditary Angioedema Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Hereditary Angioedema Sales by Distribution Channel (2016-2021) & (MT)
Table 60. Middle East & Africa Hereditary Angioedema Sales Market Share by Distribution Channel (2016-2021)
Table 61. Key and Potential Regions of Hereditary Angioedema
Table 62. Key Application and Potential Industries of Hereditary Angioedema
Table 63. Key Challenges of Hereditary Angioedema
Table 64. Key Trends of Hereditary Angioedema
Table 65. Hereditary Angioedema Distributors List
Table 66. Hereditary Angioedema Customer List
Table 67. Global Hereditary Angioedema Sales Forecast by Region (2021-2026) & (MT)
Table 68. Global Hereditary Angioedema Consumption Market Forecast by Region
Table 69. Global Hereditary Angioedema Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Hereditary Angioedema Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Hereditary Angioedema Sales Forecast by Country (2021-2026) & (MT)
Table 72. Americas Hereditary Angioedema Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Hereditary Angioedema Sales Forecast by Region (2021-2026) & (MT)
Table 74. APAC Hereditary Angioedema Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Hereditary Angioedema Sales Forecast by Country (2021-2026) & (MT)
Table 76. Europe Hereditary Angioedema Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Hereditary Angioedema Sales Forecast by Country (2021-2026) & (MT)
Table 78. Middle East & Africa Hereditary Angioedema Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Hereditary Angioedema Sales Forecast by Type (2021-2026) & (MT)
Table 80. Global Hereditary Angioedema Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Hereditary Angioedema Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Hereditary Angioedema Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Hereditary Angioedema Sales Forecast by Distribution Channel (2021-2026) & (MT)
Table 84. Global Hereditary Angioedema Sales Market Share Forecast by Distribution Channel (2021-2026)
Table 85. Global Hereditary Angioedema Revenue Forecast by Distribution Channel (2021-2026) & ($ Millions)
Table 86. Global Hereditary Angioedema Revenue Market Share Forecast by Distribution Channel (2021-2026)
Table 87. Pharming Group NV Basic Information, Hereditary Angioedema Manufacturing Base, Sales Area and Its Competitors
Table 88. Pharming Group NV Hereditary Angioedema Product Offered
Table 89. Pharming Group NV Hereditary Angioedema Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 90. Pharming Group NV Main Business
Table 91. Pharming Group NV Latest Developments
Table 92. Takeda Basic Information, Hereditary Angioedema Manufacturing Base, Sales Area and Its Competitors
Table 93. Takeda Hereditary Angioedema Product Offered
Table 94. Takeda Hereditary Angioedema Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 95. Takeda Main Business
Table 96. Takeda Latest Developments
Table 97. CSL Limited Basic Information, Hereditary Angioedema Manufacturing Base, Sales Area and Its Competitors
Table 98. CSL Limited Hereditary Angioedema Product Offered
Table 99. CSL Limited Hereditary Angioedema Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 100. CSL Limited Main Business
Table 101. CSL Limited Latest Developments
Table 102. iBio Inc. Basic Information, Hereditary Angioedema Manufacturing Base, Sales Area and Its Competitors
Table 103. iBio Inc. Hereditary Angioedema Product Offered
Table 104. iBio Inc. Hereditary Angioedema Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 105. iBio Inc. Main Business
Table 106. iBio Inc. Latest Developments
Table 107. BioCryst Pharmaceuticals, Inc. Basic Information, Hereditary Angioedema Manufacturing Base, Sales Area and Its Competitors
Table 108. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Product Offered
Table 109. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 110. BioCryst Pharmaceuticals, Inc. Main Business
Table 111. BioCryst Pharmaceuticals, Inc. Latest Developments
Table 112. Ionis Pharmaceuticals, Inc. Basic Information, Hereditary Angioedema Manufacturing Base, Sales Area and Its Competitors
Table 113. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Product Offered
Table 114. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 115. Ionis Pharmaceuticals, Inc. Main Business
Table 116. Ionis Pharmaceuticals, Inc. Latest Developments
List of Figures
Figure 1. Picture of Hereditary Angioedema
Figure 2. Hereditary Angioedema Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hereditary Angioedema Sales Growth Rate 2016-2026 (MT)
Figure 7. Global Hereditary Angioedema Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Hereditary Angioedema Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of C1 Esterase Inhibitor
Figure 10. Product Picture of Kallikrein Inhibitor
Figure 11. Product Picture of Selective Bradykinin B2 Receptor Antagonist
Figure 12. Global Hereditary Angioedema Sales Market Share by Type in 2020
Figure 13. Global Hereditary Angioedema Revenue Market Share by Type (2016-2021)
Figure 14. Hereditary Angioedema Consumed in Retail Pharmacies
Figure 15. Global Hereditary Angioedema Market: Retail Pharmacies (2016-2021) & (MT)
Figure 16. Hereditary Angioedema Consumed in Hospital Pharmacies
Figure 17. Global Hereditary Angioedema Market: Hospital Pharmacies (2016-2021) & (MT)
Figure 18. Hereditary Angioedema Consumed in Online Pharmacies
Figure 19. Global Hereditary Angioedema Market: Online Pharmacies (2016-2021) & (MT)
Figure 20. Global Hereditary Angioedema Sales Market Share by Distribution Channel (2016-2021)
Figure 21. Global Hereditary Angioedema Revenue Market Share by Distribution Channel in 2020
Figure 22. Hereditary Angioedema Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Hereditary Angioedema Revenue Market Share by Company in 2020
Figure 24. Global Hereditary Angioedema Sales Market Share by Regions (2016-2021)
Figure 25. Global Hereditary Angioedema Revenue Market Share by Region in 2020
Figure 26. Americas Hereditary Angioedema Sales 2016-2021 (MT)
Figure 27. Americas Hereditary Angioedema Revenue 2016-2021 ($ Millions)
Figure 28. APAC Hereditary Angioedema Sales 2016-2021 (MT)
Figure 29. APAC Hereditary Angioedema Revenue 2016-2021 ($ Millions)
Figure 30. Europe Hereditary Angioedema Sales 2016-2021 (MT)
Figure 31. Europe Hereditary Angioedema Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Hereditary Angioedema Sales 2016-2021 (MT)
Figure 33. Middle East & Africa Hereditary Angioedema Revenue 2016-2021 ($ Millions)
Figure 34. Americas Hereditary Angioedema Sales Market Share by Country in 2020
Figure 35. Americas Hereditary Angioedema Revenue Market Share by Country in 2020
Figure 36. Americas Hereditary Angioedema Sales Market Share by Type in 2020
Figure 37. Americas Hereditary Angioedema Sales Market Share by Distribution Channel in 2020
Figure 38. United States Hereditary Angioedema Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Hereditary Angioedema Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Hereditary Angioedema Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Hereditary Angioedema Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Hereditary Angioedema Sales Market Share by Region in 2020
Figure 43. APAC Hereditary Angioedema Revenue Market Share by Regions in 2020
Figure 44. APAC Hereditary Angioedema Sales Market Share by Type in 2020
Figure 45. APAC Hereditary Angioedema Sales Market Share by Distribution Channel in 2020
Figure 46. China Hereditary Angioedema Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Hereditary Angioedema Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Hereditary Angioedema Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Hereditary Angioedema Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Hereditary Angioedema Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Hereditary Angioedema Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Hereditary Angioedema Sales Market Share by Country in 2020
Figure 53. Europe Hereditary Angioedema Revenue Market Share by Country in 2020
Figure 54. Europe Hereditary Angioedema Sales Market Share by Type in 2020
Figure 55. Europe Hereditary Angioedema Sales Market Share by Distribution Channel in 2020
Figure 56. Germany Hereditary Angioedema Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Hereditary Angioedema Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Hereditary Angioedema Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Hereditary Angioedema Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Hereditary Angioedema Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Hereditary Angioedema Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Hereditary Angioedema Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Hereditary Angioedema Sales Market Share by Type in 2020
Figure 64. Middle East & Africa Hereditary Angioedema Sales Market Share by Distribution Channel in 2020
Figure 65. Egypt Hereditary Angioedema Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Hereditary Angioedema Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Hereditary Angioedema Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Hereditary Angioedema Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Hereditary Angioedema Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles

※본 조사보고서 [세계의 유전성 혈관부종 시장예측 2021년-2026년] (코드 : LPI-2201K00039) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 유전성 혈관부종 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 유전성 암 검사 시장예측 2021년-2026년
LPI-2201K00125 / LP Information / 2021년 12월 / 본 조사보고서는 유전성 암 검사의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Hereditary Cancer Testing will have significant change from previous year. By the most conservative estimates of global Hereditary Cancer Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 제약품 온도 제어 포장 솔루션 시장예측 2021년-2026년
LPI-2201K02276 / LP Information / 2021년 12월 / 본 조사보고서는 제약품 온도 제어 포장 솔루션의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일,...According to this latest study, the 2021 growth of Pharmaceuticals Temperature Controlled Packaging Solutions will have significant change from previous year. By the most conservative estimates of global Pharmaceuticals Temperature Controlled Packaging Solutions market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from...

세계의 메벤다졸 시장예측 2021년-2026년
LPI-2201K00101 / LP Information / 2021년 12월 / 본 조사보고서는 메벤다졸의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2021 growth of Mebendazole will have significant change from previous year. By the most conservative estimates of global Mebendazole market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 108.9 million in 2020. Over the next...

세계의 올란자핀 시장예측 2021년-2026년
LPI-2201K02112 / LP Information / 2021년 12월 / 본 조사보고서는 올란자핀의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2021 growth of Olanzapine will have significant change from previous year. By the most conservative estimates of global Olanzapine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 185.9 million in 2020. Over the next...

세계의 기면증 치료제 시장예측 2021년-2026년
LPI-2201K02236 / LP Information / 2021년 12월 / 본 조사보고서는 기면증 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Narcolepsy Therapeutics will have significant change from previous year. By the most conservative estimates of global Narcolepsy Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 1158.5 million in 2020. Over...

세계의 메니에르병 치료제 파이프 라인 시장예측 2021년-2026년
LPI-2201K02225 / LP Information / 2021년 12월 / 본 조사보고서는 메니에르병 치료제 파이프 라인의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Meniere Disease Drug Pipeline will have significant change from previous year. By the most conservative estimates of global Meniere Disease Drug Pipeline market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 과민성 대장증후군 (IBS) 시장예측 2021년-2026년
LPI-2201K00075 / LP Information / 2021년 12월 / 본 조사보고서는 과민성 대장증후군 (IBS)의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Irritable Bowel Syndrome (IBS) will have significant change from previous year. By the most conservative estimates of global Irritable Bowel Syndrome (IBS) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 4041...